1-4 of 4
Hitoshi Hanamoto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Follow-up of Patients with Aplastic Anemia Enrolled in Phase 2/3 Trials of Immunosuppressive Therapy Plus Romiplostim As a First-Line Treatment: Two-Year Interim Analysis

Kohei Hosokawa, Jong Wook Lee, Jun Ho Jang, Naoshi Obara, Masashi Sawa, Kensuke Usuki, Gaku Oshikawa, Masahiro Kizaki, Koji Nagafuji, Ting-An Lin, Hitoshi Hanamoto, Yeung-Chul Mun, Toshiro Kawakita, Kazunori Imada, June-Won Cheong, Sung-Soo Park, Takayuki Tabayashi, Masaru Gamou, Mami Shimizu, Kenta Murotani, Hirohito Yamazaki
Journal: Blood
Blood (2024) 144 (Supplement 1): 1310.
https://doi.org/10.1182/blood-2024-193925
Published: 2024
Journal Articles

ASXL1 Mutations Predict a Poor Response to Darbepoetin Alfa in Anemic Patients with Low-Risk MDS: A Multicenter, Phase II Study

Hitoshi Hanamoto, Yasuyoshi Morita, Motoshi Ichikawa, Yasuhito Nannya, MD PhD, Hirohiko Shibayama, MD PhD, Yoshinobu Maeda, MD, Tomoko Hata, Toshihiro Miyamoto, MD PhD, Hiroshi Kawabata, MD PhD, Kazuto Takeuchi, Hiroko Tanaka, Junji Kishimoto, Satoru Miyano, PhD, Itaru Matsumura, MDPhD, Seishi Ogawa, MD PhD, Koichi Akashi, MD PhD, Yuzuru Kanakura, MD PhD, Kinuko Mitani
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-134483
Published: 2020
Journal Articles

Reduced-Dosage Of Three Drugs Combination Of Cyclophosphamide, Bortezomib and Dexamethasone (reduced-CyBorD) Is Suitable For Elderly Frail Patients With Multiple Myeloma

Hideo Yagi, MD, PhD, Ryosuke Fujiwara, M.D., Keigo Sano, M.D., Keiko Yamazaki, M.D., Hitoshi Hanamoto, M.D., Ph.D., Kazuo Tsubaki, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1963.
https://doi.org/10.1182/blood.V122.21.1963.1963
Published: 2013
Journal Articles

Reduced-Dosage of Three Drugs Combination of Cyclophosphamide, Bortezomib and Dexamethasone (reduced-CyBorD) Retains High Response Rate with Less Toxicities in Elderly Patients with Multiple Myeloma

Hideo Yagi, MD, PhD, Ryosuke Fujiwara, M.D., Keigo Sano, M.D., Fujita Mariko, M.D., Takashi Iizuka, M.D., Keiko Yamazaki, M.D., Hitoshi Hanamoto, M.D., Ph.D., Kazuo Tubaki, M.D., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 1865.
https://doi.org/10.1182/blood.V120.21.1865.1865
Published: 2012